AstraZeneca reportedly bids $10 billion for US biotech Rhythm Pharmaceuticals
Pharmaceutical group AstraZeneca has made a bid worth SEK 97 billion for US-listed Rhythm Pharmaceuticals, sources told the Wall Street Journal (WSJ).
BusinessPharmaceutical group AstraZeneca has made a bid worth SEK 97 billion for US-listed Rhythm Pharmaceuticals, sources told the Wall Street Journal (WSJ).
BusinessThe Stockholm Stock Exchange’s broad OMXS index first fell, then rose, before turning down again. It closed down 0.1 percent.
BusinessPharmaceutical giant AstraZeneca exceeds market expectations in the third quarter.
BusinessThe Stockholm Stock Exchange's broad OMXS index is down 0.3 percent. Pharmaceutical giant AstraZeneca rises after its quarterly report.
BusinessSeveral AI leaders have raised the alarm after so-called AI agents escaped and caused data breaches. Nvidia CEO Jensen Huang is not among them. No Swedish company should ever appear in a newspaper article because of an AI agent incident, he said during a visit to Sweden.
BusinessMajor bank SEB fell sharply on the Stockholm Stock Exchange after being reprimanded by the Swedish Financial Supervisory Authority (the financial regulator). The broad OMXS index, however, rose 0.2 percent.
BusinessRising market interest rates and energy prices are weighing on stock markets around the world. In Stockholm, the broad OMXS index fell 0.7 percent on Thursday.
BusinessThe Stockholm Stock Exchange ends the trading week with a slight decline. The broad OMXS index fell 1.0 percent.
Business